A good reason to let the price slump: I have been involved with companies that are looking down the barrel of a pending settlement. If the court case comes to a settlement (ie, Viaderma et al have to give some money to Keough to end the case), the less the company is worth, the less you have to pay.
If they settle for a percentage of the company's value in cash instead of shares, then you have to hand over less cash if the company is worth less.
One example is a trust I was involved with where the widow took against the trust after taking what she was given in the company founder's will.
She was able to take against the trust due to an antiquated law that made it so wives would not be dealt out of their fortunes by being given their house but no piece of the company.
We got a call one evening during negotiations and the lawyers said a tentative deal had been reached. The wife would get 1/3 of the company as the law stated, in cash, but they dropped the value of the company from around 1 million to 200,000. So, the son only had to write a check for around $ 70,000 to his step mom, instead of $ 333,333.
This may be why Otiko et al are allowing the company to whither on the vine, not releasing new PR's and not shipping, so as to not have VDRM be that much more of a gem to fight for and pay for.
Just a thought as we see VDRM winning in court but not promoting itself.
